Company Overview & Business Model
Founded in April 2024, Inito Health Tech Private Limited, operating under the brand Inito, is decisively positioned at the forefront of at-home diagnostics for women’s fertility and hormonal health. From the very beginning, the company has focused on one clear mission: bringing lab-grade fertility insights directly into consumers’ hands.
At the heart of this vision lies Inito’s flagship product—a smartphone-connected fertility monitor capable of measuring multiple hormones, including Estrogen, LH, PdG, and FSH, using a simple urine sample. As a result, fertility tracking is no longer based on assumptions or averages. Instead, it evolves into a data-driven, clinically grounded diagnostic experience, delivered seamlessly at home.
Business Model Highlights
- Product-first, data-led approach
- Hardware-enabled diagnostics with strong recurring consumable potential
- Robust D2C orientation with global consumer appeal
- High switching costs once users integrate into long-term fertility journeys
Consequently, Inito is not merely selling a device. Rather, it is embedding itself deeply into ongoing reproductive health decisions, creating durable user engagement and long-term value.
Product & Technology Strength
What truly sets Inito apart is its multi-hormone measurement capability, representing a decisive leap beyond traditional single-metric ovulation kits. Moreover, its seamless smartphone integration ensures that insights are not only accurate but also actionable.
Specifically, the platform enables:
- Real-time hormonal insights
- Longitudinal data tracking across cycles
- Highly personalized fertility windows
As a result, Inito effectively replaces guesswork with precision medicine. Through its in-house fertility lab and the Inito Starter Kit, the company measures actual hormone values—Estrogen and LH to predict fertile days, PdG (a urine metabolite of progesterone) to confirm ovulation, and FSH to track follicle development. All of this is delivered through a single, consumer-friendly solution.
Operational & Financial Ratio Analysis (2025)
Key Ratios
| Ratio | Value |
| Current Ratio | ~1.31x |
| Fixed Asset Turnover | ~15.7x |
| Cash-to-Assets Ratio | ~32% |
Insight: The available ratios clearly signal operational discipline, capital efficiency, and scalability, even while the company remains in a deliberate investment phase.
Deal Flow & Capital Raising
| Deal Date | Round | Deal Size (₹ Cr) | Post-Money Valuation (₹ Cr) | Key Investors |
| Apr 2025 | Series A | 129.22 | 544.9 | Fireside Ventures, Raju Gilani, Ajay Sarupria, Baldota Family Office, Whass Esolutions Private Limited, Siddharth Ramesh Kejriwal, Harshad Reddy, and Chaitanya Kejriwal |
| Dec 2025 | Series B | 261.98 | Undisclosed | Bertelsmann India Investments, Fireside Ventures |
Total Primary Capital Raised: ~₹ 391.2 Cr
At a glance, the table highlights consistent valuation step-ups, repeat institutional backing, and strong late-stage investor confidence.
Shareholding & Governance Strength
Post-dilution Stake as of 11 Dec 2025.
| Shareholder | Percent Stake (%) |
| Inito Health INC | 38.8 |
| Individuals | 37.7 |
| Fireside Ventures | 22.0 |
| Baldota Family Office | 1.2 |
| Ikp Knowledge Park | 0.2 |
| Whass Esolutions Private Limited | 0.1 |
This structure ensures:
- Founder continuity
- Institutional discipline
- Strategic oversight
Inito maintains a balanced and strategically aligned ownership structure
Talent, Compliance & Operating Maturity
Operationally, Inito continues to scale with intent. Employee strength increased sharply from 162 to 267 within just six months, underscoring aggressive execution across functions. Additionally, consistent EPFO compliance reflects formal workforce practices and strengthens governance credibility.
Forward Outlook & Investment Thesis
In conclusion, Inito Health Tech Private Limited stands at a defining inflection point. While short-term losses are evident, they are decisively outweighed by:
- Strong capitalization
- Rapid team and product scaling
- Premium valuation benchmarks
- Clear global market relevance
Therefore, from both an investor and strategic standpoint, Inito represents a high-conviction, long-duration compounding opportunity within the rapidly expanding femtech ecosystem. In essence, the foundation is firmly laid, the momentum is unmistakable, and the runway ahead is long.
Trusted by investors and institutions, PrivateCircle enables faster, data-backed decisions across India’s private markets.